SIMCERE PHARMACEUTICAL GROUP Accounts Receivable
SIMCERE PHARMACEUTICAL GROUP had Accounts Receivable of CNY 413.48 million as of 2012-12-31, per its 20-F filed 2013-04-26.
Discontinued › Balance Sheet › Assets › Assets, Current › Accounts and Financing Receivable, after Allowance for Credit Loss, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2013-04-26
- 2012-12-31: Accounts Receivable, after Allowance for Credit Loss, Current 413.48M CNY.
- 2011-12-31: Accounts Receivable, after Allowance for Credit Loss, Current 462.05M CNY.
CNY
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2012-12-31 | 413.48M CNY 20-F · filed 2013-04-26 |
| 2011-12-31 | 462.05M CNY 20-F · filed 2013-04-26 |
USD
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2012-12-31 | $66.37M 20-F · filed 2013-04-26 |